Here we perform affinity purification mass spectrometry (AP-MS) on post-mortem AD brain tissue with antibodies targeting the pT217 epitope to determine if these interactions vary from more ‘mature’ phosphorylated tau species and can highlight potential early interactions related to AD pathogenesis. The gene discussed is MAPT; the disease is Alzheimer disease.